Distributions (number and proportion) of statin doses as simvastatin equivalents at initiation and after 1 year of follow-up according to statin prescriptions redeemed by all patients with diabetes and by those without cardiovascular disease at statin initiation between 2005 and 2008 and surviving the following first year
| Real-world patients with diabetes (all) | Real-world patients with diabetes and without cardiovascular disease | |||
|---|---|---|---|---|
| Total number of patients | N=45 463 | N=33 219 | ||
| Simvastatin (C10AA01) equivalent dose* | At initiation | After follow-up | At initiation | After follow-up |
| 5 mg | 142 (<1) | 185 (<1) | 105 (<1) | 142 (<1) |
| 10 mg | 12 180 (27) | 11 079 (24) | 9645 (29) | 8671 (26) |
| 20 mg | 23 671 (52) | 23 065 (51) | 17 803 (54) | 17 364 (52) |
| 40 mg | 7178 (16) | 8508 (19) | 4097 (12) | 5261 (16) |
| 80 mg | 2017 (4) | 2197 (5) | 1409 (4) | 1518 (5) |
| >80 mg | 225 (<1) | 368 (<1) | 120 (<1) | 216 (<1) |
*For equivalence, atorvastatin 10 mg=fluvastatin 80 mg=lovastatin 40 mg=pravastatin 40 mg=simvastatin 20 mg ≤rosuvastatin 5 mg.29